Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fruit | 22 | 2024 | 1158 | 2.830 |
Why?
|
Vegetables | 22 | 2024 | 1192 | 2.720 |
Why?
|
Colorectal Neoplasms | 50 | 2024 | 6919 | 2.320 |
Why?
|
Coffee | 8 | 2021 | 593 | 1.950 |
Why?
|
Diet | 45 | 2024 | 8048 | 1.870 |
Why?
|
Receptors, Estrogen | 6 | 2021 | 2208 | 1.590 |
Why?
|
Tea | 6 | 2020 | 288 | 1.570 |
Why?
|
Vitamins | 9 | 2023 | 1634 | 1.500 |
Why?
|
Carotenoids | 9 | 2022 | 621 | 1.500 |
Why?
|
Dairy Products | 8 | 2023 | 490 | 1.480 |
Why?
|
Feeding Behavior | 18 | 2020 | 3183 | 1.090 |
Why?
|
Breast Neoplasms | 25 | 2023 | 20982 | 1.050 |
Why?
|
Prospective Studies | 92 | 2024 | 54435 | 1.040 |
Why?
|
Folic Acid | 9 | 2021 | 1323 | 1.030 |
Why?
|
Glioma | 13 | 2022 | 3452 | 1.020 |
Why?
|
Financial Management | 3 | 2024 | 160 | 1.010 |
Why?
|
Alcohol Drinking | 18 | 2023 | 4027 | 1.000 |
Why?
|
Risk Factors | 101 | 2024 | 74239 | 0.920 |
Why?
|
Vitamin D | 12 | 2023 | 3301 | 0.880 |
Why?
|
Dietary Fats | 7 | 2017 | 1994 | 0.870 |
Why?
|
Pancreatic Neoplasms | 9 | 2024 | 5366 | 0.800 |
Why?
|
Vitamin A | 5 | 2017 | 612 | 0.800 |
Why?
|
Calcium, Dietary | 7 | 2023 | 529 | 0.790 |
Why?
|
Eggs | 4 | 2020 | 182 | 0.770 |
Why?
|
Diet Surveys | 11 | 2020 | 1161 | 0.760 |
Why?
|
Proportional Hazards Models | 34 | 2022 | 12474 | 0.760 |
Why?
|
Carbonated Beverages | 3 | 2011 | 210 | 0.740 |
Why?
|
Meat | 3 | 2016 | 584 | 0.720 |
Why?
|
Ovarian Neoplasms | 8 | 2017 | 4872 | 0.690 |
Why?
|
Ascorbic Acid | 4 | 2015 | 654 | 0.680 |
Why?
|
Colonic Neoplasms | 7 | 2022 | 2527 | 0.670 |
Why?
|
Cohort Studies | 45 | 2024 | 41496 | 0.650 |
Why?
|
Weight Loss | 3 | 2022 | 2680 | 0.650 |
Why?
|
Body Mass Index | 18 | 2021 | 12952 | 0.640 |
Why?
|
Vitamin E | 4 | 2015 | 872 | 0.630 |
Why?
|
Receptors, Progesterone | 3 | 2019 | 1129 | 0.610 |
Why?
|
Risk | 20 | 2023 | 9616 | 0.590 |
Why?
|
Diet, Mediterranean | 6 | 2022 | 738 | 0.580 |
Why?
|
Vitamin D Deficiency | 4 | 2023 | 1388 | 0.580 |
Why?
|
Multivariate Analysis | 21 | 2021 | 12052 | 0.580 |
Why?
|
Phaseolus | 1 | 2017 | 16 | 0.580 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2018 | 1462 | 0.570 |
Why?
|
Dietary Fiber | 6 | 2020 | 758 | 0.560 |
Why?
|
Adenoma | 10 | 2021 | 2159 | 0.560 |
Why?
|
Caffeine | 2 | 2018 | 701 | 0.560 |
Why?
|
Calcium | 5 | 2023 | 5719 | 0.530 |
Why?
|
Premenopause | 5 | 2020 | 1039 | 0.510 |
Why?
|
Female | 134 | 2024 | 392544 | 0.510 |
Why?
|
Menopause | 4 | 2020 | 1646 | 0.480 |
Why?
|
Incidence | 33 | 2024 | 21365 | 0.480 |
Why?
|
Weight Gain | 4 | 2022 | 2349 | 0.480 |
Why?
|
Follow-Up Studies | 39 | 2023 | 39126 | 0.470 |
Why?
|
Lung Neoplasms | 16 | 2023 | 13385 | 0.470 |
Why?
|
Carcinoma, Renal Cell | 6 | 2009 | 3163 | 0.470 |
Why?
|
Middle Aged | 97 | 2024 | 220853 | 0.470 |
Why?
|
North America | 9 | 2015 | 1284 | 0.460 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11101 | 0.450 |
Why?
|
Humans | 169 | 2024 | 761208 | 0.440 |
Why?
|
Aged | 77 | 2024 | 169288 | 0.440 |
Why?
|
Dietary Supplements | 8 | 2017 | 3410 | 0.430 |
Why?
|
Guideline Adherence | 2 | 2021 | 2220 | 0.430 |
Why?
|
Seafood | 1 | 2016 | 393 | 0.420 |
Why?
|
Postmenopause | 7 | 2022 | 2514 | 0.420 |
Why?
|
Adult | 86 | 2024 | 221119 | 0.410 |
Why?
|
Vitamin D-Binding Protein | 3 | 2020 | 130 | 0.410 |
Why?
|
Body Height | 5 | 2020 | 1566 | 0.410 |
Why?
|
Male | 102 | 2024 | 360693 | 0.400 |
Why?
|
Xanthophylls | 1 | 2012 | 94 | 0.400 |
Why?
|
Lutein | 2 | 2012 | 123 | 0.400 |
Why?
|
Europe | 11 | 2020 | 3423 | 0.390 |
Why?
|
Body Weight | 3 | 2022 | 4618 | 0.380 |
Why?
|
Anthropometry | 2 | 2018 | 1338 | 0.370 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 487 | 0.370 |
Why?
|
Vitamin B 6 | 3 | 2018 | 234 | 0.370 |
Why?
|
beta Carotene | 2 | 2012 | 523 | 0.360 |
Why?
|
Antioxidants | 3 | 2010 | 1667 | 0.360 |
Why?
|
Case-Control Studies | 21 | 2021 | 22174 | 0.340 |
Why?
|
Risk Assessment | 20 | 2021 | 24021 | 0.340 |
Why?
|
Carbohydrates | 1 | 2011 | 389 | 0.330 |
Why?
|
Odds Ratio | 14 | 2019 | 9652 | 0.320 |
Why?
|
Overweight | 1 | 2020 | 2418 | 0.320 |
Why?
|
Health Personnel | 8 | 2021 | 3337 | 0.320 |
Why?
|
Kynurenine | 2 | 2021 | 141 | 0.320 |
Why?
|
Kidney Neoplasms | 4 | 2009 | 4251 | 0.310 |
Why?
|
Exercise | 4 | 2022 | 5874 | 0.300 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 550 | 0.300 |
Why?
|
Dietary Sucrose | 1 | 2010 | 243 | 0.300 |
Why?
|
Cholesterol | 5 | 2023 | 2902 | 0.300 |
Why?
|
Obesity | 7 | 2023 | 12939 | 0.290 |
Why?
|
United States | 43 | 2024 | 72339 | 0.290 |
Why?
|
Anticarcinogenic Agents | 2 | 2006 | 249 | 0.280 |
Why?
|
Beverages | 3 | 2022 | 821 | 0.280 |
Why?
|
Flavonoids | 2 | 2020 | 444 | 0.270 |
Why?
|
Alcoholic Beverages | 3 | 2023 | 264 | 0.270 |
Why?
|
Soybean Proteins | 1 | 2006 | 55 | 0.260 |
Why?
|
Lactose | 1 | 2006 | 95 | 0.260 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2017 | 318 | 0.260 |
Why?
|
Research Design | 8 | 2022 | 6180 | 0.250 |
Why?
|
Dietary Proteins | 2 | 2020 | 951 | 0.250 |
Why?
|
Neoplasms | 8 | 2023 | 22140 | 0.240 |
Why?
|
Liver Neoplasms | 5 | 2022 | 4309 | 0.240 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2017 | 344 | 0.240 |
Why?
|
Calibration | 4 | 2022 | 819 | 0.240 |
Why?
|
Food, Fortified | 2 | 2021 | 189 | 0.230 |
Why?
|
Aged, 80 and over | 16 | 2020 | 58952 | 0.220 |
Why?
|
Body Size | 2 | 2018 | 463 | 0.220 |
Why?
|
Diet Records | 5 | 2020 | 427 | 0.220 |
Why?
|
Brassica | 1 | 2022 | 39 | 0.210 |
Why?
|
Vitamin B Complex | 3 | 2017 | 299 | 0.210 |
Why?
|
Epidemiologic Methods | 2 | 2006 | 1336 | 0.210 |
Why?
|
Wine | 1 | 2023 | 166 | 0.210 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2019 | 2293 | 0.210 |
Why?
|
Fabaceae | 1 | 2022 | 103 | 0.200 |
Why?
|
Nutrition Surveys | 4 | 2023 | 1723 | 0.200 |
Why?
|
Leisure Activities | 2 | 2022 | 308 | 0.200 |
Why?
|
C-Peptide | 3 | 2018 | 442 | 0.200 |
Why?
|
gamma-Tocopherol | 1 | 2022 | 30 | 0.200 |
Why?
|
Risk Reduction Behavior | 3 | 2020 | 1111 | 0.200 |
Why?
|
Colonic Polyps | 3 | 2021 | 552 | 0.200 |
Why?
|
Brain Neoplasms | 5 | 2021 | 9025 | 0.190 |
Why?
|
Motor Activity | 4 | 2022 | 2712 | 0.190 |
Why?
|
Inflammation | 6 | 2019 | 10759 | 0.190 |
Why?
|
Waist Circumference | 3 | 2020 | 933 | 0.190 |
Why?
|
Nutrition Assessment | 3 | 2020 | 727 | 0.190 |
Why?
|
Adenocarcinoma | 3 | 2022 | 6341 | 0.190 |
Why?
|
Adenomatous Polyps | 1 | 2002 | 109 | 0.190 |
Why?
|
Pesticide Residues | 1 | 2022 | 95 | 0.190 |
Why?
|
Glycemic Index | 1 | 2023 | 396 | 0.190 |
Why?
|
Cotinine | 2 | 2018 | 206 | 0.180 |
Why?
|
Herpesviridae Infections | 1 | 2022 | 269 | 0.180 |
Why?
|
Food Handling | 1 | 2020 | 154 | 0.170 |
Why?
|
Prebiotics | 1 | 2020 | 41 | 0.170 |
Why?
|
Yogurt | 1 | 2020 | 71 | 0.170 |
Why?
|
Food | 3 | 2023 | 768 | 0.170 |
Why?
|
Hyperinsulinism | 1 | 2022 | 400 | 0.170 |
Why?
|
Republic of Korea | 1 | 2021 | 576 | 0.170 |
Why?
|
Pesticides | 1 | 2022 | 296 | 0.160 |
Why?
|
Polyomavirus Infections | 1 | 2021 | 192 | 0.160 |
Why?
|
Biological Specimen Banks | 2 | 2021 | 780 | 0.160 |
Why?
|
Waist-Hip Ratio | 3 | 2019 | 518 | 0.160 |
Why?
|
Mice, SCID | 1 | 2023 | 2621 | 0.150 |
Why?
|
Somatotypes | 1 | 2018 | 41 | 0.150 |
Why?
|
Adiponectin | 3 | 2023 | 1107 | 0.150 |
Why?
|
Gonadal Steroid Hormones | 2 | 2019 | 702 | 0.150 |
Why?
|
Sex Factors | 9 | 2021 | 10553 | 0.150 |
Why?
|
International Agencies | 1 | 2019 | 244 | 0.150 |
Why?
|
alpha-Tocopherol | 2 | 2017 | 126 | 0.150 |
Why?
|
Periodontitis | 1 | 2022 | 568 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 625 | 0.140 |
Why?
|
Eating | 3 | 2019 | 1535 | 0.140 |
Why?
|
Interleukin-6 | 2 | 2017 | 3210 | 0.140 |
Why?
|
Life Style | 5 | 2023 | 3907 | 0.140 |
Why?
|
Age Factors | 5 | 2021 | 18384 | 0.140 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 173 | 0.130 |
Why?
|
Herpesvirus 1, Human | 1 | 2022 | 739 | 0.130 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2011 | 361 | 0.130 |
Why?
|
Digestive System Neoplasms | 1 | 2016 | 83 | 0.130 |
Why?
|
Smoking | 9 | 2020 | 9055 | 0.130 |
Why?
|
Probiotics | 1 | 2020 | 378 | 0.130 |
Why?
|
Nurses | 4 | 2021 | 2477 | 0.130 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2023 | 1933 | 0.130 |
Why?
|
Vitamin B 12 | 1 | 2019 | 524 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 614 | 0.130 |
Why?
|
Reproductive History | 1 | 2016 | 210 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 828 | 0.120 |
Why?
|
Milk | 4 | 2023 | 440 | 0.120 |
Why?
|
Methionine | 1 | 2018 | 570 | 0.120 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1052 | 0.120 |
Why?
|
Statistics as Topic | 2 | 2016 | 2359 | 0.120 |
Why?
|
Linear Models | 6 | 2019 | 5869 | 0.120 |
Why?
|
Obesity, Abdominal | 1 | 2018 | 373 | 0.120 |
Why?
|
Allied Health Personnel | 1 | 2016 | 154 | 0.120 |
Why?
|
Ethanol | 2 | 2015 | 1322 | 0.120 |
Why?
|
Adipose Tissue | 1 | 2007 | 3313 | 0.120 |
Why?
|
C-Reactive Protein | 2 | 2017 | 3821 | 0.120 |
Why?
|
Tooth Loss | 1 | 2016 | 200 | 0.120 |
Why?
|
Hyperlipidemias | 1 | 2019 | 771 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2021 | 982 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 731 | 0.120 |
Why?
|
Epidemiology | 1 | 2017 | 280 | 0.120 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 554 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 607 | 0.110 |
Why?
|
Resistance Training | 1 | 2016 | 192 | 0.110 |
Why?
|
Prognosis | 8 | 2019 | 29687 | 0.110 |
Why?
|
Health Occupations | 2 | 2018 | 223 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2017 | 329 | 0.110 |
Why?
|
Carbon | 1 | 2017 | 665 | 0.110 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2018 | 424 | 0.110 |
Why?
|
Young Adult | 10 | 2021 | 59221 | 0.110 |
Why?
|
Periodontal Diseases | 1 | 2016 | 450 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1089 | 0.110 |
Why?
|
Triglycerides | 1 | 2021 | 2457 | 0.110 |
Why?
|
Estrogens | 2 | 2019 | 1522 | 0.100 |
Why?
|
Asia | 3 | 2020 | 622 | 0.100 |
Why?
|
Lipids | 2 | 2023 | 3331 | 0.100 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2054 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1156 | 0.100 |
Why?
|
Adiposity | 2 | 2019 | 1879 | 0.100 |
Why?
|
Insulin | 4 | 2023 | 6588 | 0.100 |
Why?
|
Receptors, Calcitriol | 1 | 2014 | 360 | 0.100 |
Why?
|
Hemeproteins | 1 | 2011 | 61 | 0.100 |
Why?
|
International Cooperation | 1 | 2018 | 1423 | 0.100 |
Why?
|
Diet, Vegetarian | 2 | 2024 | 180 | 0.090 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2465 | 0.090 |
Why?
|
Data Interpretation, Statistical | 2 | 2018 | 2691 | 0.090 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20119 | 0.090 |
Why?
|
Iron, Dietary | 1 | 2011 | 148 | 0.090 |
Why?
|
Premature Birth | 1 | 2022 | 1784 | 0.090 |
Why?
|
Nutrition Policy | 3 | 2011 | 466 | 0.090 |
Why?
|
Aspirin | 2 | 2012 | 3129 | 0.090 |
Why?
|
Anthocyanins | 2 | 2020 | 80 | 0.090 |
Why?
|
Seasons | 1 | 2016 | 1518 | 0.080 |
Why?
|
Patient Compliance | 1 | 2000 | 2688 | 0.080 |
Why?
|
Sample Size | 2 | 2022 | 843 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1885 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1176 | 0.080 |
Why?
|
Adolescent | 7 | 2023 | 88298 | 0.080 |
Why?
|
Ferritins | 1 | 2011 | 596 | 0.080 |
Why?
|
Magnesium | 1 | 2012 | 804 | 0.080 |
Why?
|
Up-Regulation | 1 | 2017 | 4111 | 0.080 |
Why?
|
Cholesterol, Dietary | 1 | 2008 | 224 | 0.080 |
Why?
|
Acetaminophen | 1 | 2012 | 555 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12159 | 0.070 |
Why?
|
Sweetening Agents | 1 | 2010 | 290 | 0.070 |
Why?
|
Tryptophan | 2 | 2021 | 480 | 0.070 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2008 | 224 | 0.070 |
Why?
|
Zinc | 1 | 2011 | 672 | 0.070 |
Why?
|
Disease Progression | 1 | 2023 | 13511 | 0.070 |
Why?
|
Organizations, Nonprofit | 1 | 2007 | 105 | 0.070 |
Why?
|
Coronary Disease | 1 | 2020 | 5921 | 0.070 |
Why?
|
Health Surveys | 4 | 2019 | 4037 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4021 | 0.060 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15520 | 0.060 |
Why?
|
Sleep | 1 | 2021 | 4759 | 0.060 |
Why?
|
Logistic Models | 5 | 2022 | 13249 | 0.060 |
Why?
|
Selenium Compounds | 1 | 2004 | 11 | 0.060 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11119 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3245 | 0.060 |
Why?
|
Menarche | 2 | 2016 | 532 | 0.060 |
Why?
|
Minnesota | 2 | 2002 | 337 | 0.060 |
Why?
|
Australia | 2 | 2018 | 1246 | 0.060 |
Why?
|
Meat Products | 1 | 2024 | 96 | 0.050 |
Why?
|
Confidence Intervals | 5 | 2010 | 2928 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2006 | 554 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2020 | 2854 | 0.050 |
Why?
|
Time Factors | 6 | 2021 | 39957 | 0.050 |
Why?
|
Beer | 1 | 2023 | 134 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2007 | 793 | 0.050 |
Why?
|
Homocysteine | 1 | 2006 | 637 | 0.050 |
Why?
|
Alcohol Dehydrogenase | 1 | 2003 | 113 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 1702 | 0.050 |
Why?
|
Root Planing | 1 | 2022 | 74 | 0.050 |
Why?
|
Parity | 1 | 2006 | 929 | 0.050 |
Why?
|
Mouthwashes | 1 | 2022 | 57 | 0.050 |
Why?
|
Mendelian Randomization Analysis | 2 | 2019 | 1010 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26071 | 0.050 |
Why?
|
Finland | 1 | 2024 | 607 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2270 | 0.050 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 276 | 0.050 |
Why?
|
Self Report | 3 | 2020 | 3727 | 0.050 |
Why?
|
Poultry | 1 | 2022 | 80 | 0.050 |
Why?
|
Calcifediol | 1 | 2023 | 160 | 0.050 |
Why?
|
Minerals | 1 | 2023 | 281 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2023 | 415 | 0.050 |
Why?
|
Colonoscopy | 3 | 2008 | 1395 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15920 | 0.050 |
Why?
|
Regression Analysis | 4 | 2017 | 6345 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2003 | 4243 | 0.050 |
Why?
|
Chlorhexidine | 1 | 2022 | 160 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10203 | 0.050 |
Why?
|
Cause of Death | 3 | 2021 | 3688 | 0.050 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 1381 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 2 | 2016 | 1208 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10756 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 399 | 0.040 |
Why?
|
Flavones | 1 | 2020 | 68 | 0.040 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2000 | 88 | 0.040 |
Why?
|
Postpartum Period | 1 | 2007 | 1178 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2006 | 751 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15841 | 0.040 |
Why?
|
Fructose | 1 | 2022 | 285 | 0.040 |
Why?
|
Flavonols | 1 | 2020 | 85 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10218 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2014 | 3198 | 0.040 |
Why?
|
Norway | 1 | 2021 | 499 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11476 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5321 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7400 | 0.040 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2019 | 241 | 0.040 |
Why?
|
Dehydroepiandrosterone | 1 | 2019 | 258 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2004 | 6223 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 103 | 0.040 |
Why?
|
CpG Islands | 1 | 2022 | 1190 | 0.040 |
Why?
|
Carcinoma, Large Cell | 1 | 2018 | 113 | 0.040 |
Why?
|
Tumor Burden | 1 | 2023 | 1892 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2022 | 750 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2016 | 5842 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3873 | 0.040 |
Why?
|
Metabolic Equivalent | 1 | 2016 | 15 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8003 | 0.030 |
Why?
|
Hormones | 1 | 2000 | 868 | 0.030 |
Why?
|
Chronic Disease | 3 | 2024 | 9319 | 0.030 |
Why?
|
Animals | 7 | 2024 | 168079 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10088 | 0.030 |
Why?
|
Pharyngeal Neoplasms | 1 | 2016 | 113 | 0.030 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 1998 | 292 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1076 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 4014 | 0.030 |
Why?
|
DNA Methylation | 2 | 2022 | 4384 | 0.030 |
Why?
|
Poverty | 1 | 2007 | 2691 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2017 | 330 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2023 | 3592 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2330 | 0.030 |
Why?
|
Siblings | 1 | 2019 | 824 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2023 | 8530 | 0.030 |
Why?
|
Gallbladder Neoplasms | 1 | 2016 | 189 | 0.030 |
Why?
|
Likelihood Functions | 1 | 1998 | 991 | 0.030 |
Why?
|
Biological Availability | 1 | 2015 | 389 | 0.030 |
Why?
|
Educational Status | 1 | 2002 | 2510 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3307 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1807 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 2016 | 315 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2017 | 716 | 0.030 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2013 | 18 | 0.030 |
Why?
|
Laboratories | 1 | 2017 | 462 | 0.030 |
Why?
|
Alcoholism | 1 | 2004 | 1973 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4851 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 677 | 0.030 |
Why?
|
History, 21st Century | 1 | 2019 | 1567 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1772 | 0.030 |
Why?
|
Pregnancy | 2 | 2022 | 29893 | 0.030 |
Why?
|
Women's Health | 1 | 2022 | 2070 | 0.030 |
Why?
|
Androgens | 1 | 2019 | 1283 | 0.020 |
Why?
|
Demography | 1 | 1997 | 1641 | 0.020 |
Why?
|
History, 16th Century | 1 | 2011 | 70 | 0.020 |
Why?
|
Age Distribution | 2 | 2008 | 2871 | 0.020 |
Why?
|
Mouth Neoplasms | 1 | 2016 | 596 | 0.020 |
Why?
|
Progesterone | 1 | 2015 | 742 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2472 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3584 | 0.020 |
Why?
|
Colon | 1 | 2019 | 1791 | 0.020 |
Why?
|
Gene Frequency | 1 | 2018 | 3603 | 0.020 |
Why?
|
Data Collection | 1 | 2000 | 3320 | 0.020 |
Why?
|
Boston | 2 | 2017 | 9327 | 0.020 |
Why?
|
Blood Glucose | 1 | 2023 | 6392 | 0.020 |
Why?
|
Time | 1 | 2011 | 545 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1186 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2019 | 2553 | 0.020 |
Why?
|
Consumer Health Information | 1 | 2011 | 215 | 0.020 |
Why?
|
Breast Feeding | 1 | 2016 | 1356 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 9278 | 0.020 |
Why?
|
Mass Media | 1 | 2011 | 303 | 0.020 |
Why?
|
Estradiol | 1 | 2015 | 1937 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10422 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2023 | 16952 | 0.020 |
Why?
|
Ursodeoxycholic Acid | 1 | 2006 | 81 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1457 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1658 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2016 | 2877 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17897 | 0.020 |
Why?
|
World Health Organization | 1 | 2011 | 1321 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3418 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6067 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15308 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18220 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2277 | 0.010 |
Why?
|
Folic Acid Deficiency | 1 | 2003 | 117 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12728 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2016 | 3952 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26199 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5081 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11067 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14610 | 0.010 |
Why?
|
Qualitative Research | 1 | 2011 | 3024 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16575 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15721 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14025 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30002 | 0.010 |
Why?
|
Genotype | 2 | 2003 | 12985 | 0.010 |
Why?
|
Poisson Distribution | 1 | 1998 | 504 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81326 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 1999 | 998 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2006 | 12341 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42224 | 0.010 |
Why?
|
Child | 2 | 2014 | 80152 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 1998 | 1662 | 0.010 |
Why?
|
Registries | 1 | 2004 | 8247 | 0.000 |
Why?
|